19 octubre 2015
Rheumatologists have been analyzing clinical data on biosimilars that have already been approved for use. The term ‘biosimilars’ refers to drugs that mimic the effects of biologics. A particular focus of the article is the efficacy of biosimilars that have already been approved for the treatment of rheumatic diseases within the past three years.
http://www.sciencedaily.com/releases/2015/10/151019103755.htm
